Global contract research organisation Syngene International Limited announced the resignation of Dr. Joydeep Kant as Senior Vice President – Development Services of the company, with effect from October 31, 2023. According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), this is to inform…
Syngene International Limited announced the signing of a 10- year agreement with animal health company, Zoetis, to manufacture the drug substance for Librela (bedinvetmab), a first in class monoclonal antibody used for treating osteoarthritis in dogs. Launched in Europe, the UK and Switzerland, the product won ‘Best new companion animal product’ by IHS Markit Connect…
Syngene International, an integrated research, development, and manufacturing services company, has appointed two senior leaders, Alex Del Priore and Dr. Alan Collis, with effect from 26th July 2021. Alex Del Priore has been appointed as the Senior Vice President, Manufacturing Services. Alan Collis joins as the Vice President, Integrated Drug Discovery services. They will both…
Syngene International, an integrated research, development and manufacturing services company, has appointed Sanjeev Sukumaran as Chief Human Resource Officer (CHRO) with effect from 1st June, 2021. Sanjeev succeeded Vinita Shrivastava. As the CHRO, Sanjeev will be responsible for building on Syngene’s people-centric organizational development priorities including HR strategy development, driving organisational matrices, talent management and sustaining…
Syngene International Limited, a leading global contract research organisation, has appointed Sibaji Biswas as Chief Financial Officer and member of the Executive Committee with effect from December 18, 2019. He will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a new role. …